826 related articles for article (PubMed ID: 24277079)
1. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
2. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
Front Immunol; 2020; 11():613278. PubMed ID: 33542720
[TBL] [Abstract][Full Text] [Related]
3. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
5. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
6. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells.
Zhang P; Nguyen J; Abdulla F; Nelson AT; Beckman JD; Vercellotti GM; Belcher JD
Front Immunol; 2021; 12():632709. PubMed ID: 33841413
[TBL] [Abstract][Full Text] [Related]
7. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
8. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
9. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes.
Sultana C; Shen Y; Rattan V; Johnson C; Kalra VK
Blood; 1998 Nov; 92(10):3924-35. PubMed ID: 9808586
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
11. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
[TBL] [Abstract][Full Text] [Related]
12. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
[TBL] [Abstract][Full Text] [Related]
13. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.
Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rh1 protects human endothelial cells against lipopolysaccharide-induced inflammatory injury through inhibiting TLR2/4-mediated STAT3, NF-κB, and ER stress signaling pathways.
Jin Y; Nguyen TLL; Myung CS; Heo KS
Life Sci; 2022 Nov; 309():120973. PubMed ID: 36150463
[TBL] [Abstract][Full Text] [Related]
15. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.
Belcher JD; Marker PH; Weber JP; Hebbel RP; Vercellotti GM
Blood; 2000 Oct; 96(7):2451-9. PubMed ID: 11001897
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin increases leukocyte adhesion and initiates lung microvascular endothelial activation via Toll-like receptor 4 signaling.
Conger AK; Tomasek T; Riedmann KJ; Douglas JS; Berkey LE; Ware LB; Bastarache JA; Meegan JE
Am J Physiol Cell Physiol; 2023 Mar; 324(3):C665-C673. PubMed ID: 36717098
[TBL] [Abstract][Full Text] [Related]
17. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM
Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369
[TBL] [Abstract][Full Text] [Related]
18. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.
Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769
[TBL] [Abstract][Full Text] [Related]
19. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease.
Bashi A; Lekpor C; Hood JL; Thompson WE; Stiles JK; Driss A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
